Literature DB >> 30392897

S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine.

Claus W Heizmann1.   

Abstract

S100 proteins are members of the superfamily of Ca2+-binding proteins characterized by the specific Ca2+-binding motif, the EF-hand. Proteins of this superfamily are of clinical use as important diagnostic and prognostic biomarkers in adult and pediatric Laboratory Medicine. For example, measurements of troponin are nowadays the 'gold standard' in the diagnosis of patients with acute coronary syndrome. Parvalbumins were identified as major fish allergens and blocking antibodies, induced by immunization with a hypoallergenic parvalbumin mutant, were shown to reduce allergic symptoms. Mutations in calmodulin are linked to inherited ventricular tachycardia, and cardiac arrhythmias. S100 proteins, the largest sub-group within the EF-hand protein family, are closely associated with cardiovascular diseases, various types of cancer, inflammation and autoimmune pathologies and brain diseases. The intention of this review is to focus on the clinical use of S100 proteins as biomarkers and potential drug targets helping to improve the diagnosis of these human diseases in children and adults leading to more selective therapeutic interventions.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allergy; Biomarkers; Calcium-binding; Cancer; Cardiomyopathy; Clinical chemistry; Diagnostic; Drug targets; EF-hand; Head injury; Inflammation; Laboratory medicine; S100 proteins

Mesh:

Substances:

Year:  2018        PMID: 30392897     DOI: 10.1016/j.bbamcr.2018.10.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  8 in total

1.  D-SCRIPT translates genome to phenome with sequence-based, structure-aware, genome-scale predictions of protein-protein interactions.

Authors:  Samuel Sledzieski; Rohit Singh; Lenore Cowen; Bonnie Berger
Journal:  Cell Syst       Date:  2021-10-09       Impact factor: 11.091

Review 2.  Zooming into the Dark Side of Human Annexin-S100 Complexes: Dynamic Alliance of Flexible Partners.

Authors:  Judith Weisz; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

Review 3.  Friend or Foe: S100 Proteins in Cancer.

Authors:  Chantal Allgöwer; Anna-Laura Kretz; Silvia von Karstedt; Mathias Wittau; Doris Henne-Bruns; Johannes Lemke
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

4.  S100A1 as a potential biomarker for the diagnosis of patients with acute aortic dissection.

Authors:  Chenjun Han; Qiang Liu; Yuanmin Li; Wangfu Zang; Jian Zhou
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

5.  Interferon-β Activity Is Affected by S100B Protein.

Authors:  Alexey S Kazakov; Alexander D Sofin; Nadezhda V Avkhacheva; Evgenia I Deryusheva; Victoria A Rastrygina; Maria E Permyakova; Vladimir N Uversky; Eugene A Permyakov; Sergei E Permyakov
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

Review 6.  A Structural Perspective on Calprotectin as a Ligand of Receptors Mediating Inflammation and Potential Drug Target.

Authors:  Velia Garcia; Yasiru Randika Perera; Walter Jacob Chazin
Journal:  Biomolecules       Date:  2022-03-30

Review 7.  S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases.

Authors:  Katarzyna Kurpet; Grażyna Chwatko
Journal:  Molecules       Date:  2022-10-06       Impact factor: 4.927

8.  Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis.

Authors:  Eszter Anna Janka; Tünde Várvölgyi; Zoltán Sipos; Alexandra Soós; Péter Hegyi; Szabolcs Kiss; Fanni Dembrovszky; Dezső Csupor; Patrik Kéringer; Dániel Pécsi; Margit Solymár; Gabriella Emri
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.